Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Connors

Showing results (471-480 of 977) with videos related to

Pageof 98
Sort By:
Nature Reviews. Disease Primers|October 21, 2021
Author Correction: Hodgkin lymphomaJoseph M Connors, Wendy Cozen, Christian Steidl, et al.
Clinical Breast Cancer|September 29, 2012
Treatment and outcomes of primary breast lymphomaJulianna Caon, Elaine S Wai, Jason Hart, et al.
Nature Reviews. Disease Primers|July 25, 2020
Hodgkin lymphomaJoseph M Connors, Wendy Cozen, Christian Steidl, et al.
Cytogenetic and Genome Research|November 23, 2011
SNP analysis of minimally evolved t(14;18)(q32;q21)-positive follicular lymphomas reveals a common copy-neutral loss of heterozygosity patternK J Cheung, S Rogic, S Ben-Neriah, et al.
British Journal of Haematology|October 8, 2019
Brentuximab vedotin for the treatment of patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplantationPanayotis Kaloyannidis, Mark Hertzberg, Kate Webb, et al.
Nature Medicine|May 6, 1999
HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppressionC J Pitcher, C Quittner, D M Peterson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
Hepatitis C infection and B-cell non-Hodgkin's lymphoma in British Columbia: a cross-sectional analysisS Shariff, E M Yoshida, R D Gascoyne, et al.
Anesthesiology|April 1, 1996
Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver diseaseM Dershwitz, J F Hoke, C E Rosow, et al.
Journal of Thrombosis and Thrombolysis|July 12, 2020
Evaluation and optimization of prescribed concomitant antiplatelet and anticoagulation therapy centrally managed by an anticoagulation management serviceSara A Zekery-Saad, Andrea Lewin, Magie Pham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2012
Incidence of transformation to aggressive lymphoma in limited-stage follicular lymphoma treated with radiotherapyP Bains, A Al Tourah, B A Campbell, et al.
Pageof 98

Showing results (471-480 of 977) with videos related to

Sort By:
Pageof 98
Nature Reviews. Disease Primers|October 21, 2021
Author Correction: Hodgkin lymphomaJoseph M Connors, Wendy Cozen, Christian Steidl, et al.
Clinical Breast Cancer|September 29, 2012
Treatment and outcomes of primary breast lymphomaJulianna Caon, Elaine S Wai, Jason Hart, et al.
Nature Reviews. Disease Primers|July 25, 2020
Hodgkin lymphomaJoseph M Connors, Wendy Cozen, Christian Steidl, et al.
Cytogenetic and Genome Research|November 23, 2011
SNP analysis of minimally evolved t(14;18)(q32;q21)-positive follicular lymphomas reveals a common copy-neutral loss of heterozygosity patternK J Cheung, S Rogic, S Ben-Neriah, et al.
British Journal of Haematology|October 8, 2019
Brentuximab vedotin for the treatment of patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplantationPanayotis Kaloyannidis, Mark Hertzberg, Kate Webb, et al.
Nature Medicine|May 6, 1999
HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppressionC J Pitcher, C Quittner, D M Peterson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
Hepatitis C infection and B-cell non-Hodgkin's lymphoma in British Columbia: a cross-sectional analysisS Shariff, E M Yoshida, R D Gascoyne, et al.
Anesthesiology|April 1, 1996
Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver diseaseM Dershwitz, J F Hoke, C E Rosow, et al.
Journal of Thrombosis and Thrombolysis|July 12, 2020
Evaluation and optimization of prescribed concomitant antiplatelet and anticoagulation therapy centrally managed by an anticoagulation management serviceSara A Zekery-Saad, Andrea Lewin, Magie Pham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2012
Incidence of transformation to aggressive lymphoma in limited-stage follicular lymphoma treated with radiotherapyP Bains, A Al Tourah, B A Campbell, et al.
Pageof 98